Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Intas Builds Europe Scale With £603m Teva Deal

Executive Summary

Intas Pharmaceuticals of India has acquired certain Teva assets in Europe – a transaction that is expected to give the unlisted Indian group significantly expanded scale in the region.

Advertisement

Related Content

Time Is Of The Essence As Teva Considers European Assets Bids
Muted Q1 For Aurobindo But Outlook Firm; Don’t Expect ‘Exotic’ M&A
India Pharma 2017: 3Cs And D (Disruption)?
India Pharma 2017: 3Cs And D (Disruption)?
Deal Watch: Takeda Seeks A Crescendo With Collaboration On New Type Of Cancer Compound
Intas' MD On Acquiring Best-Performing Assets And Brexit
Teva Embarks On New Phase With FTC Clearance Of Allergan Generics
Allergan's UK Generics Business Up For Sale Under EC Merger Condition
Intas bolsters European hospitals supplies base via Spanish deal

Topics

Related Companies

Related Deals

What to read next

Advertisement
UsernamePublicRestriction

Register

SC097426

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

All set! This Question has been sent to my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel